Ligand Pharmaceuticals (LGND) Current Deferred Tax Assets (2011 - 2015)

Ligand Pharmaceuticals has disclosed Current Deferred Tax Assets across 4 years of filings, most recently posting $7.5 million for Q3 2015.

• Current Deferred Tax Assets for Q3 2015 came in at $7.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2015 was $7.5 million (changed N/A YoY), and the FY2012 annual result was $8000.0, down 96.62% from the prior year.
• Current Deferred Tax Assets came in at $7.5 million for Q3 2015 at Ligand Pharmaceuticals, up from $8000.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $7.5 million in Q3 2015 to a low of $8000.0 in Q4 2012.
• The 4-year median for Current Deferred Tax Assets is $237000.0 (2011), against an average of $1.1 million.
• Peak annual rise in Current Deferred Tax Assets reached 80.15% in 2012, while the deepest fall reached 96.62% in 2012.
• Ligand Pharmaceuticals' Current Deferred Tax Assets stood at $237000.0 in 2011, then tumbled by 96.62% to $8000.0 in 2012, then changed by 0.0% to $8000.0 in 2013, then jumped by 93862.5% to $7.5 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $7.5 million (Q3 2015), $8000.0 (Q3 2013), and $8000.0 (Q2 2013), per Business Quant data.